Digy

 

LIT M Tablets

Composition

Each tablet contains:
Montelukast sodium IP equivalent to montelukast……………10 mg
Levocetirizine dihydrochloride IP…………………………………….5 mg

Indications

LIT M Tablets  tablets is indicated for relief of symptoms of allergic rhinitis (seasonal and perennial). LIT M indicated for prevention of exercise-induced broncho-constriction in patients 6 years of age and older.

Dosage and Administration

LIT M Tablets
Adults     1 tablet once daily

Contraindications

LIT M Tablets are contraindicated in patients with known hypersensitivity to montelukast,  levocetirizine, to other piperazine derivatives or to any of the excipients. Also, contradicted in patients with severe renal impairment at less than 10 ml/min creatinine clearance. Children 6 months to 11 years of age with impaired renal function should not be administered LIT M Dispersible tablets .

Packaging Information

LIT M Tablets……………Blister pack of 10 tablets